Upcoming event
EAU UROonco: A meeting steered by the EAU Section of Oncological Urology
Back

Tags

Article of the Month, ASCO GU22, ASCO21, AUA21, Cabozantinib, Carcinoma, Chronic kidney disease, Cryosurgery, EAU, EAU21, EAU22, EMUC21, EMUC22, ERUS22, ESMO21, Frail patient​, Glomerular filtration rate, Guidelines, IMDC risk model, Kidney cancer, Laparoscopy, Lymph node metastases, Lymph nodes, Metastasectomy, Mortality, Neoplasm metastasis, Neoplasm recurrence, Nephrectomy, Nephron-sparing surgery, Nivolumab, Overall survival, Partial nephrectomy, Prognostication, Radical nephrectomy, Radical surgery, RCC, Renal cancer, Renal cell, Renal cell carcinoma, Renal Cell Carcinoma guidelines, Renal cryoablation, Renal function, Renal Transplantation, Renorrhaphy, Robotic, Robotic prostatectomy, Robotic surgery, Survival outcome, Suture, Targeted therapies, Treatment response, Urological surgery, UROonco24, UROwebinar, Webinar
Show all

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

Nature, February 2025

View

Advancing non-invasive renal cell carcinoma diagnostics: Proteomic insights from urinary extracellular vesicles

EAU25, March 2025

View

The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent axitinib (axi)

EAU25, March 2025

View

Intratumoral microbiota composition regulates tumor progression in clear cell renal cell carcinoma

EAU25, March 2025

View

Validation of the UICC 8th T staging system and potential refinement with renal parenchymal infiltration or micronodular spread in clear cell renal cell carcinoma

EAU25, March 2025

View

Preoperative prediction of adherent perirenal fat based on CT radiomics combined with deep learning: A prospective, multicenter study

EAU25, March 2025

View

Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial

ASCO GU25, February 2025

View

Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC-313

ASCO GU25, February 2025

View

KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and targeted therapy combinations for advanced clear cell renal cell carcinoma (ccRCC)

ASCO GU25, February 2025

View

Clinical applications of microbiome in renal cell carcinoma

European Urology Focus, January 2025

View

Abdominal noncontrast computed tomography scanning to screen for kidney cancer and other abdominal pathology within community-based computed tomography screening for lung cancer: Results of the Yorkshire kidney screening trial

European Urology, September 2024

View

[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

The LANCET Oncology, October 2024

View
Next